Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Schizophrenia, bipolar disorder, and major depressive disorder (MDD) have all been associated with immune system dysfunction, including aberrant cerebrospinal fluid (CSF) levels of cytokines and tryptophan catabolites; however, the pattern of alterations has not been compared across disorders. We performed a meta-analysis of CSF cytokine and tryptophan catabolites in patients with these major psychiatric disorders. METHODS: Articles were identified by searching Pub Med, PsycInfo, and Web of Science, and the reference lists of these studies. RESULTS: Twenty-eight studies met the inclusion criteria (16 schizophrenia, 4 bipolar disorder, and 9 MDD). CSF levels of IL-1β and kynurenic acid were significantly increased in patients with schizophrenia and bipolar disorder compared to healthy controls (P < .001). CSF levels of IL-6 and IL-8 were significantly increased in patients with schizophrenia and MDD compared to healthy controls (P ≤ .013). DISCUSSION: There is preliminary evidence for similarities in the pattern of CSF cytokine and tryptophan catabolite alterations across major psychiatric disorders, although findings must be interpreted with caution in light of small numbers of studies/subjects. Many CSF alterations are also concordant with those in the peripheral blood, particularly for schizophrenia. Findings have important implications for our understanding of the pathophysiology and treatment of major psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
Funnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Florencio-Silva, R., Sasso, G. R. D. S., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S. (2015) · BioMed Research International · doi:10.1155/2015/421746 · Cited by 2,044
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Self-citationGlial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLES
COCHRAN, W. G. (1950) · Biometrika · doi:10.1093/biomet/37.3-4.256 · Cited by 1,465
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium (2015) · Nature Neuroscience · doi:10.1038/nn.3922 · Cited by 755
van Berckel, B. N., Bossong, M. G., Boellaard, R., Kloet, R., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A. D., Cahn, W., Lammertsma, A. A., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.025 · Cited by 582
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Doorduin, J., de Vries, E. F. J., Willemsen, A. T. M., de Groot, J. C., Dierckx, R. A., & Klein, H. C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066647 · Cited by 559
Lindqvist, D., Janelidze, S., Hagell, P., Erhardt, S., Samuelsson, M., Minthon, L., Hansson, O., Björkqvist, M., Träskman-Bendz, L., & Brundin, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.030 · Cited by 524
ELISA and Multiplex Technologies for Cytokine Measurement in Inflammation and Aging Research
Leng, S. X., McElhaney, J. E., Walston, J. D., Xie, D., Fedarko, N. S., & Kuchel, G. A. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.8.879 · Cited by 516
Cytokines and schizophrenia: microglia hypothesis of schizophrenia
Monji, A., Kato, T., & Kanba, S. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01945.x · Cited by 508
O’Connor, M.-F., Bower, J. E., Cho, H. J., Creswell, J. D., Dimitrov, S., Hamby, M. E., Hoyt, M. A., Martin, J. L., Robles, T. F., Sloan, E. K., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.04.005 · Cited by 500
The role of inflammation in schizophrenia
Müller, N., Weidinger, E., Leitner, B., & Schwarz, M. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00372 · Cited by 465
Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes
Hamidi, M., Drevets, W. C., & Price, J. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.006 · Cited by 369
Cerebrospinal Cytokine Levels in Patients with Acute Depression
Levine, J., Barak, Y., Chengappa, K. N. R., Rapoport, A., Rebey, M., & Barak, V. (1999) · Neuropsychobiology · doi:10.1159/000026615 · Cited by 354
Connecting inflammation with glutamate agonism in suicidality
Erhardt, S., Lim, C. K., Linderholm, K. R., Janelidze, S., Lindqvist, D., Samuelsson, M., Lundberg, K., Postolache, T. T., Träskman-Bendz, L., Guillemin, G. J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.248 · Cited by 345
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Sommer, I. E., van Westrhenen, R., Begemann, M. J. H., de Witte, L. D., Leucht, S., & Kahn, R. S. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt139 · Cited by 342
Cytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis
Maimone, D., Gregory, S., Arnason, B. G. W., & Reder, A. T. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90073-g · Cited by 333
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Linderholm, K. R., Skogh, E., Olsson, S. K., Dahl, M.-L., Holtze, M., Engberg, G., Samuelsson, M., & Erhardt, S. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq086 · Cited by 325
Bay-Richter, C., Linderholm, K. R., Lim, C. K., Samuelsson, M., Träskman-Bendz, L., Guillemin, G. J., Erhardt, S., & Brundin, L. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.07.012 · Cited by 304
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Sathyasaikumar, K. V., Stachowski, E. K., Wonodi, I., Roberts, R. C., Rassoulpour, A., McMahon, R. P., & Schwarcz, R. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq112 · Cited by 253
Methods for Exploring Heterogeneity in Meta-Analysis
Song, F., Sheldon, T. A., Sutton, A. J., Abrams, K. R., & Jones, D. R. (2001) · Evaluation & the Health Professions · doi:10.1177/01632780122034849 · Cited by 253
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia
Nilsson, L. K., Linderholm, K. R., Engberg, G., Paulson, L., Blennow, K., Lindström, L. H., Nordin, C., Karanti, A., Persson, P., & Erhardt, S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.013 · Cited by 238
Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders
Gibney, S. M., & Drexhage, H. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9462-8 · Cited by 234
Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Gassama, B., Sebastian, D., Buckley, P., & Mellor, A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.007 · Cited by 233
Self-citationNetwork beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Myint, A.-M., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.008 · Cited by 230
Kynurenines: from the perspective of major psychiatric disorders
Myint, A. M. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08551.x · Cited by 229
Schwieler, L., Larsson, M. K., Skogh, E., Kegel, M. E., Orhan, F., Abdelmoaty, S., Finn, A., Bhat, M., Samuelsson, M., Lundberg, K., et al. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140126 · Cited by 226
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
Tourjman, V., Kouassi, É., Koué, M.-È., Rocchetti, M., Fortin-Fournier, S., Fusar-Poli, P., & Potvin, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.011 · Cited by 224
Nitta, M., Kishimoto, T., Müller, N., Weiser, M., Davidson, M., Kane, J. M., & Correll, C. U. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt070 · Cited by 204
Sasayama, D., Hattori, K., Wakabayashi, C., Teraishi, T., Hori, H., Ota, M., Yoshida, S., Arima, K., Higuchi, T., Amano, N., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.12.001 · Cited by 199
Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.9.1408 · Cited by 185
Baumeister, D., Ciufolini, S., & Mondelli, V. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4044-5 · Cited by 183
Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder
Söderlund, J., Olsson, S. K., Samuelsson, M., Walther-Jallow, L., Johansson, C., Erhardt, S., Landén, M., & Engberg, G. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100080 · Cited by 183
Activation of brain interleukin-1β in schizophrenia
Söderlund, J., Schröder, J., Nordin, C., Samuelsson, M., Walther-Jallow, L., Karlsson, H., Erhardt, S., & Engberg, G. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.52 · Cited by 179
Immunology of Major Depression
Müller, N. (2014) · Neuroimmunomodulation · doi:10.1159/000356540 · Cited by 174
The Immunology of Bipolar Disorder
Barbosa, I. G., Machado‐Vieira, R., Soares, J. C., & Teixeira, A. L. (2014) · NeuroImmunoModulation · doi:10.1159/000356539 · Cited by 160
Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype
Garver, D. L., Tamas, R. L., & Holcomb, J. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300217 · Cited by 148
Pearlman, D. M., & Najjar, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.001 · Cited by 132
Martinez, J. M., Garakani, A., Yehuda, R., & Gorman, J. M. (2012) · Depression and Anxiety · doi:10.1002/da.20876 · Cited by 131
A systematic, quantitative review of blood autoantibodies in schizophrenia
Ezeoke, A., Mellor, A. L., Buckley, P. F., & Miller, B. J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.029 · Cited by 131
Self-citationImbalanced Kynurenine Pathway in Schizophrenia
Kegel, M. E., Bhat, M., Skogh, E., Samuelsson, M., Lundberg, K., Dahl, M., Sellgren, C. M., Schwieler, L., Engberg, G., Schuppe‐Koistinen, I., et al. (2014) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s16800 · Cited by 122
Inflammatory Molecular Signature Associated With Infectious Agents in Psychosis
Hayes, L. N., Severance, E. G., Leek, J. T., Gressitt, K. L., Rohleder, C., Coughlin, J. M., Leweke, F. M., Yolken, R. H., & Sawa, A. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu052 · Cited by 115
Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder
Olsson, S. K., Samuelsson, M., Saetre, P., Lindström, L., Jönsson, E. G., Nordin, C., Engberg, G., Erhardt, S., & Landén, M. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090180 · Cited by 112
Barak, V., Barak, Y., Levine, J., Nisman, B., & Roisman, I. (1995) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1995.6.1.61 · Cited by 103
Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications
Gaspar, P. A., Bustamante, M. L., Hernán Silva, I., & Aboitiz, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06325.x · Cited by 102
Lower subjective social status exaggerates interleukin-6 responses to a laboratory stressor
Derry, H. M., Fagundes, C. P., Andridge, R., Glaser, R., Malarkey, W. B., & Kiecolt-Glaser, J. K. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.06.026 · Cited by 98
Kynurenine pathway in psychosis: evidence of increased tryptophan degradation
Barry, S., Clarke, G., Scully, P., & Dinan, T. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108089583 · Cited by 96
Association between Insulin Resistance and Breast Carcinoma: A Systematic Review and Meta-Analysis
Hernández, A. V., Guarnizo, M., Miranda, Y., Pasupuleti, V., Deshpande, A., Paico-Palacios, S., Lenti, H., Ganoza, S., Montalvo, L., Thota, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099317 · Cited by 95
Kern, S., Skoog, I., Börjesson-Hanson, A., Blennow, K., Zetterberg, H., Östling, S., Kern, J., Gudmundsson, P., Marlow, T., Rosengren, L., et al. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.05.006 · Cited by 94
Elevated interleukin-6 in schizophrenia
van Kammen, D. P., McAllister, C. G., Kelley, M. E., Gurklis, J. A., & Yao, J. K. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00053-0 · Cited by 93
Chiappelli, J., Pocivavsek, A., Nugent, K. L., Notarangelo, F. M., Kochunov, P., Rowland, L. M., Schwarcz, R. M., & Hong, L. E. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.243 · Cited by 93
Berardis, D. D., Conti, C. M., Serroni, N., Moschetta, F. S., Olivieri, L., Carano, A., Salerno, R. M., Cavuto, M., Farina, B., Alessandrini, M., et al. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300204 · Cited by 91
Pålhagen, S., Qi, H., Mårtensson, B., Wålinder, J., Granérus, A., & Svenningsson, P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5353-6 · Cited by 88
Olsson, S. K., Sellgren, C. M., Engberg, G., Landén, M., & Erhardt, S. (2012) · Bipolar Disorders · doi:10.1111/bdi.12009 · Cited by 87
The essential roles of TGFB1 in reproduction
Ingman, W. V., & Robertson, S. A. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.05.003 · Cited by 82
Cytokines, epilepsy and epileptic drugs--is there a mutual influence?
Młodzikowska-Albrecht, J., Steinborn, B., & Żarowski, M. (2007) · PubMed · Cited by 81
Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression
Carpenter, L. L., Heninger, G. R., Malison, R. T., Tyrka, A. R., & Price, L. H. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00460-3 · Cited by 79
Isgren, A., Jakobsson, J., Pålsson, E., Ekman, C. J., Johansson, A. G. M., Sellgren, C. M., Blennow, K., Zetterberg, H., & Landén, M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.10.001 · Cited by 72
Ayorech, Z., Tracy, D. K., Baumeister, D., & Giaroli, G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.015 · Cited by 62
Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders.
Ravikumar, A., Deepadevi, K. V., Arun, P., Manojkumar, V., & Kurup, P. A. (2000) · PubMed · Cited by 59
Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus.
Dellalibera-Joviliano, R., dos Reis, M. L., Cunha, F. Q., & Donadi, E. A. (2003) · PubMed · Cited by 56
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers
Rapaport, M. H., McAllister, C. G., Pickar, D., Tamarkin, L., Kirch, D. G., & Paul, S. M. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00008-x · Cited by 54
Interleukin-1α and interleukin-2 in cerebrospinal fluid of schizophrenic subjects
El‐Mallakh, R. S., Suddath, R. L., & Wyatt, R. J. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90072-z · Cited by 50
Banati, R. B., & Hickie, I. B. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02371.x · Cited by 47
Katila, H., Hurme, M., Wahlbeck, K., Appelberg, B., & Rimón, R. (2008) · Neuropsychobiology · doi:10.1159/000119130 · Cited by 43
The TRAF6-NF kappa B signaling pathway in autoimmunity: not just inflammation.
Thomas, R. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1784 · Cited by 33
Transforming Growth Factors β1 and β2 in the Cerebrospinal Fluid of Chronic Schizophrenic Patients
Vawter, M. P. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00143-1 · Cited by 26
Regulation of Macrophage Biology by Lithium: A New Look at an Old Drug
Raghavendra, P. B., Lee, E. H., & Parameswaran, N. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9516-y · Cited by 24
Low CSF soluble interleukin 2 receptor levels in acute depression
Levine, J., Barak, Y., Chengappa, K. R., Rapoport, A., Antelman, S. M., & Barak, V. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050219 · Cited by 12
Cited by
The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136
Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Müller, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby024 · Cited by 648
Enache, D., Pariante, C. M., & Mondelli, V. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.015 · Cited by 615
“A recent meta-analysis focused specifically on CSF cytokines in patients with MDD, schizophrenia and bipolar disorder, and found increased CSF levels of IL-6 and IL8 in these patients (Wang and Miller, 2018); however, this systematic review and metaanalysis did not include two previous studies, which focused exclusive…”
BackgroundResultMetagenome-wide association of gut microbiome features for schizophrenia
Zhu, F., Ju, Y., Wang, W., Wang, Q., Guo, R., Ma, Q., Sun, Q., Fan, Y., Xie, Y., Yang, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15457-9 · Cited by 409
Han, L. K. M., Dinga, R., Hahn, T., Ching, C. R. K., Eyler, L. T., Aftanas, L., Aghajani, M., Aleman, A., Baune, B. T., Berger, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0754-0 · Cited by 334
Metadata
- Authors
- Wang, A. K., & Miller, B. J.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-17
- Volume
- 44
- Issue
- 1
- Pages
- 75-83
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2595474555
- Cited by
- 389
- References
- 76
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.